Overview
"Albert W. Wu is Professor of Health Policy and Management and Medicine, with joint appointments in Epidemiology, International Health, Medicine and Surgery. He received BA and MD degrees from Cornell University, and completed an Internal Medicine residency at the Mount Sinai Hospital and UC San Diego. He was a Robert Wood Johnson Clinical Scholar at UCSF and received an MPH from UC Berkeley. His research and teaching focus on patient outcomes and quality of care. He was the first to measure the quality of life impact of antiretroviral therapy in HIV clinical trials. He developed the MOS-HIV health survey, and other questionnaires to measure quality of life, adherence, satisfaction, attitudes and behaviors for people with chronic disease. He was co-founder and director of the outcomes research committee of the AIDS Clinical Trials Group of the NIH, and President of the International Society for Quality of Life. He advises many US and international organizations on PRO methods. He is director of the Johns Hopkins Center for Health Services and Outcomes Research, He has studied the handling of medical errors since 1988, was a member of the Institute of Medicine committee on identifying and preventing medication errors, and was Senior Adviser for Patient Safety to WHO in Geneva. His current research is on incorporating PROs into the electronic health record, PRO-performance measures for primary care, supporting healthcare workers after adverse events, and creating a network community based organizations. He has authored over 400 peer review publications. and is co-author of the recent book ""New Horizons in Patient Safety, Understanding Communication. He leads the PhD program in health services research, the Masters of Applied Science in Patient Safety & Healthcare Quality, and the Certificate program in Quality, Patient Safety and Outcomes Research in the Johns Hopkins Bloomberg School of Public Health. He maintains a clinical practice in general internal medicine.".
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Floor 7, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever.
Kathleen Neuzil is an Infectious Disease provider in Baltimore, Maryland. Dr. Neuzil is highly rated in 8 conditions, according to our data. Her top areas of expertise are Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.
The Johns Hopkins Hospital
John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is highly rated in 14 conditions, according to our data. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
We do not have enough information to identify the Areas of Expertise for this provider.